ArticleOphthalmology science2026
Data-Driven Detection of Subclinical Keratoconus via Semi-Supervised Clustering of Multidimensional Corneal Biomarkers.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Morphology to Biomarkers: Optical Coherence Tomography in Corneal Disease.Diseases (Basel, Switzerland) · 2026Review
- Unsupervised phenotyping of suspect keratoconus based on posterior tomography and epithelial remodeling.BMC ophthalmology · 2026Article
- Motion-Tracking Brillouin Microscopy for Keratoconus Suspect Identification: Comparison With Multimodal Corneal Imaging.American journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To objectively identify subclinical keratoconus (SKC) from a large sample of healthy and keratoconus (KC) patients via a data-driven framework on corneal imaging data from an anterior-segment OCT (AS-OCT) device (MS-39, CSO Italia). Design: A retrospective cohort study. Subjects: At 2 sites within the Moorfields Eye Hospital network in London, United Kingdom, 25 816 corneal scans from 5005 patients, including 3605 with KC and 1400 healthy control patients, were acquired between 2020 and 2024. Methods: Principal component analysis (PCA) followed by Gaussian mixture modeling (GMM) was applied to AS-OCT-derived data, including 20 KC indices and patient age, to identify SKC eyes, which were then statistically compared against healthy and KC eyes. Subclinical KC eyes were also validated against external systems including same-day Pentacam (Oculus Optikgeräte) scans, Belin-Ambrosio's ABCD system, KC progression criteria determined by a panel of corneal specialists, and the Moorfields Corneal Cross-linking (CXL) Risk Calculator. Main Outcome Measures: Detection of SKC and progression of these eyes to clinically diagnosable KC over time. Results: The GMM identified 166 eyes from 161 patients with distinct structural differences between healthy and KC eyes. These eyes clustered in the morphometric transition zone in PCA space and were predominantly classified as ABCD stage 0. However, they demonstrated asymmetry with their fellow eye, higher predicted CXL risk at 1-4 years ( Conclusions: Subclinical KC remains challenging to detect, and although classic staging such as ABCD retains clinical utility, it is insufficient for early disease detection. Principal component analysis followed by GMM classification on a multidimensional AS-OCT dataset identifies a distinct and high-risk SKC group. This semisupervised framework offers a complementary tool for early risk stratification and can be applied to new patients via projection into the learned PCA space and computation of KC probability. Threshold values corresponding to the 25th and 75th percentiles of KC probability for each parameter may serve as clinical context for flagging eyes when multiple features fall in the atypical range. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.